Evidence map›Paper›PMID 19773548›Full record

ArticleThe Journal of biological chemistry2009

Tyrosine phosphorylation of Kir3 following kappa-opioid receptor activation of p38 MAPK causes heterologous desensitization.

Cecilea C Clayton, Mei Xu, Charles Chavkin

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 34 citations in OpenAlex.

  1. Neuronal G protein-gated KAmerican journal of physiology. Cell physiology · 2022
    Review
  2. Loss of SUR1 subtype KBehavioural brain research · 2021
    Article
  3. Article
  4. Regulation of heterologously expressed 5-HTBritish journal of pharmacology · 2019
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
  12. Mice with compromised 5-HTT function lack phosphotyrosine-mediated inhibitory control over prefrontal 5-HT responses.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2014
    Article
  13. Repeated stress dysregulates κ-opioid receptor signaling in the dorsal raphe through a p38α MAPK-dependent mechanism.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2012
    Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Cecilea C ClaytonDepartment of Pharmacology, University of Washington, Seattle, Washington 98195, USA.
Mei Xu
Charles Chavkin
University of Washington · US

Funding

Regulation of Opioid Signaling by Tyr-PhosphorylationR37DA011672 · NIDA · UNIVERSITY OF WASHINGTON · PI CHAVKIN, CHARLES · 2004 to 2013
$2.5M
Dynorphins and Kappa Opioid Receptors in the Stress ResponseK05DA020570 · NIDA · UNIVERSITY OF WASHINGTON · PI CHAVKIN, CHARLES · 2006 to 2015
$1.2M
NIDA NIH HHS K05 DA020570NIDA NIH HHS K05 DA20570NIDA NIH HHS R37 DA011672NIDA NIH HHS R37-DA11672
6 · The paper itself

Abstract

Prior studies showed that tyrosine 12 phosphorylation in the N-terminal, cytoplasmic domain of the G-protein-gated inwardly rectifying potassium channel, K(ir)3.1 facilitates channel deactivation by increasing intrinsic GTPase activity of the channel. Using a phosphoselective antibody directed against this residue (pY12), we now report that partial sciatic nerve ligation increased pY12-K(ir)3.1-immunoreactivity (ir) in the ipsilateral dorsal horn of wild-type mice, but not in mice lacking the kappa-opioid receptor (KOR) or lacking the G-protein receptor kinase 3 (GRK3) genes. Treatment of AtT-20 cells stably expressing KOR-GFP with the selective KOR agonist U50,488 increased both phospho-p38-ir and pY12-K(ir)3.1-ir. The U50,488-induced increase in pY12-K(ir)3.1-ir was blocked by the p38 inhibitor SB203580. Cells expressing KOR(S369A)-GFP did not increase either phospho-p38-ir or pY12-K(ir)3.1-ir following U50,488 treatment. Whole cell voltage clamp of AtT-20 cells expressing KOR-GFP demonstrated that p38 activation by U50,488 reduced somatostatin-evoked K(ir)3 currents. This heterologous desensitization was blocked by SB203580 and was not evident in cells expressing KOR(S369A)-GFP. Tyrosine phosphorylation of K(ir)3.1 was likely mediated by p38 MAPK activation of Src kinase. U50,488 also increased (pY418)Src-ir; this increase was blocked by SB203580 and not evident in KOR(S369A)-GFP expressing AtT20 cells; the Src inhibitor PP2 blocked the U50,488-induced increase in pY12-K(ir)3.1-ir; and the heterologous desensitization of K(ir)3 currents was blocked by PP2. These results suggest that KOR causes phosphorylation of Y12-K(ir)3.1 and channel inhibition through a GRK3-, p38 MAPK- and Src-dependent mechanism. Reduced inward potassium current following nerve ligation would increase dorsal horn neuronal excitability and may contribute to the neuropathic pain response.

Indexed as

AnimalsElectrophysiologyG Protein-Coupled Inwardly-Rectifying Potassium ChannelsG-Protein-Coupled Receptor Kinase 3ImmunoblottingIon ChannelsMaleMiceMice, Inbred C57BLMice, Knockoutp38 Mitogen-Activated Protein KinasesPhosphorylationPituitary GlandReceptors, Opioid, kappaSciatic NerveTyrosineG Protein-Coupled Inwardly-Rectifying Potassium ChannelsG-Protein-Coupled Receptor Kinase 3GRK3 protein, mouseIon Channelsp38 Mitogen-Activated Protein KinasesReceptors, Opioid, kappaTyrosine

Identifiers

PMID19773548
PMCPMC2797258
OpenAlexW2075621262

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.